全关节置换术后围手术期阿片类药物使用的差异。
Variation in perioperative opioid use after total joint arthroplasty.
作者信息
Schumacher Charles S, Menendez Mariano E, Pagani Nicholas R, Freiberg Andrew A, Kwon Young-Min, Bedair Hany, Ring David, Rubash Harry E
机构信息
Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Department of Orthopaedic Surgery, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA.
出版信息
J Orthop. 2021 May 7;25:162-166. doi: 10.1016/j.jor.2021.05.003. eCollection 2021 May-Jun.
OBJECTIVE
We studied variation in perioperative opioid use after total joint arthroplasty with respect to patient and procedure characteristics in order to inform initiatives to optimize pain relief.
METHODS
We recorded perioperative opioid consumption for a cohort of total joint arthroplasty patients to identify factors underlying variation in perioperative opioid use.
RESULTS
Younger patient age, tobacco use, greater symptoms of depression, private insurance, and knee arthroplasty were associated with increased opioid consumption.
CONCLUSIONS
Awareness of the patient characteristics associated with increased perioperative opioid use can help inform implementation of targeted strategies for safe, optimal pain relief and satisfaction.
目的
我们研究了全关节置换术后围手术期阿片类药物使用情况随患者和手术特征的变化,以便为优化疼痛缓解的举措提供信息。
方法
我们记录了一组全关节置换术患者的围手术期阿片类药物消耗量,以确定围手术期阿片类药物使用差异的潜在因素。
结果
患者年龄较小、吸烟、抑郁症状较重、拥有私人保险以及进行膝关节置换术与阿片类药物消耗量增加有关。
结论
了解与围手术期阿片类药物使用增加相关的患者特征有助于为实施安全、最佳疼痛缓解和满意度的针对性策略提供信息。